Success Metrics

Clinical Success Rate

80.0%

Based on 4 completed trials

Completion Rate

80%(4/5)

Active Trials

0(0%)

Results Posted

25%(1 trials)

Terminated

1(14%)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

N/ANon-phased studies

7(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Terminated(1)

Other(2)

Detailed Status

Completed4

unknown2

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

N/A

Trials by Phase

N/A7 (100.0%)

Trials by Status

unknown229%

terminated114%

completed457%

Recent Activity

0 active trials

Showing 5 of 7

completednot_applicable

Clinical Trials (7)

Showing 7 of 7 trials

NCT05844852Not Applicable

P200TE US Reference Database Study

Completed

NCT06305481Not Applicable

Glaucoma Evaluation With the P200TE

Completed

NCT05624593Not Applicable

P200TE and Predicate Agreement and Precision Study

Unknown

NCT05536401Not Applicable

P200TE Agreement and Precision Study

Terminated

NCT03912584Not Applicable

Study Comparing the P200TE and the P200TxE in Glaucoma Patients

Completed

NCT03783858Not Applicable

Image Collection of Normal Eyes for Development of an EU RDB

Completed

NCT02921568Not Applicable

Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes

Unknown

All 7 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 7